Literature DB >> 21703166

Vascular invasion leaves its mark in hepatocellular carcinoma.

Aileen Marshall, Graeme Alexander.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21703166     DOI： 10.1016/j.jhep.2011.05.005

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  3 in total

1.  Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.

Authors:  Andrew Gabrielson; Yunan Wu; Hongkun Wang; Jiji Jiang; Bhaskar Kallakury; Zoran Gatalica; Sandeep Reddy; David Kleiner; Thomas Fishbein; Lynt Johnson; Eddie Island; Rohit Satoskar; Filip Banovac; Reena Jha; Jaydeep Kachhela; Perry Feng; Tiger Zhang; Anteneh Tesfaye; Petra Prins; Christopher Loffredo; John Marshall; Louis Weiner; Michael Atkins; Aiwu Ruth He
Journal:  Cancer Immunol Res       Date:  2016-03-11       Impact factor: 11.151

2.  Delivery of sFIT-1 engineered MSCs in combination with a continuous low-dose doxorubicin treatment prevents growth of liver cancer.

Authors:  Jian Niu; Yue Wang; Ji Wang; Liu Bin; Xin Hu
Journal:  Aging (Albany NY)       Date:  2016-12-28       Impact factor: 5.682

3.  Improved survival with radiotherapy in hepatocellular carcinoma with major vascular invasion: A propensity-matched analysis of Surveillance, Epidemiology, and End Results database.

Authors:  Qiuyan Lin; Xiaoquan Huang; Canmei Zhong; Tiancheng Luo; Xiaoqing Zeng; Shiyao Chen
Journal:  Cancer Med       Date:  2019-01-18       Impact factor: 4.452
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.